CVS, Aetna aim to finalize deal as early as December: sources
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health (CVS) PT Lowered to $76 at Jefferies Following 3Q
November 7, 2017 8:24 AM ESTJefferies lowered its price target on CVS Health (NYSE: CVS) to $76.00 (from $86.00) while maintaining a Hold rating. CVS reported Q3 EPS of $1.50 that beat consensus by $0.02. Similar to the last few quarters, SSS revs were pressured by weakness in front-end sales and the... More
